Class information for:
Level 1: DUAL BLOCKADE//RENOPROTECTION//NONDIABETIC RENAL DISEASE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
859 2919 42.1 76%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
464 15237 MICROALBUMINURIA//GLOMERULAR FILTRATION RATE//CYSTATIN C

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DUAL BLOCKADE Author keyword 17 70% 0% 14
2 RENOPROTECTION Author keyword 15 25% 2% 54
3 NONDIABETIC RENAL DISEASE Author keyword 11 69% 0% 9
4 ANGIOTENSIN RECEPTOR BLOCKERS Author keyword 7 12% 2% 58
5 MIDELFORT CLIN Address 7 53% 0% 9
6 NEGRI BERGAMO S Address 7 41% 0% 13
7 ANGIOTENSIN RECEPTOR BLOCKER Author keyword 7 11% 2% 58
8 DOUBLING OF SERUM CREATININE Author keyword 6 80% 0% 4
9 KIDNEY END POINT Author keyword 6 80% 0% 4
10 CLIN RARE DIS ALDO CELE DACCO Address 6 21% 1% 23

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 DUAL BLOCKADE 17 70% 0% 14 Search DUAL+BLOCKADE Search DUAL+BLOCKADE
2 RENOPROTECTION 15 25% 2% 54 Search RENOPROTECTION Search RENOPROTECTION
3 NONDIABETIC RENAL DISEASE 11 69% 0% 9 Search NONDIABETIC+RENAL+DISEASE Search NONDIABETIC+RENAL+DISEASE
4 ANGIOTENSIN RECEPTOR BLOCKERS 7 12% 2% 58 Search ANGIOTENSIN+RECEPTOR+BLOCKERS Search ANGIOTENSIN+RECEPTOR+BLOCKERS
5 ANGIOTENSIN RECEPTOR BLOCKER 7 11% 2% 58 Search ANGIOTENSIN+RECEPTOR+BLOCKER Search ANGIOTENSIN+RECEPTOR+BLOCKER
6 DOUBLING OF SERUM CREATININE 6 80% 0% 4 Search DOUBLING+OF+SERUM+CREATININE Search DOUBLING+OF+SERUM+CREATININE
7 KIDNEY END POINT 6 80% 0% 4 Search KIDNEY+END+POINT Search KIDNEY+END+POINT
8 RENIN ANGIOTENSIN SYSTEM BLOCKADE 5 43% 0% 9 Search RENIN+ANGIOTENSIN+SYSTEM+BLOCKADE Search RENIN+ANGIOTENSIN+SYSTEM+BLOCKADE
9 NEPHROSCLEROSIS 5 16% 1% 29 Search NEPHROSCLEROSIS Search NEPHROSCLEROSIS
10 RAAS BLOCKADE 5 41% 0% 9 Search RAAS+BLOCKADE Search RAAS+BLOCKADE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CONVERTING ENZYME INHIBITION 86 14% 20% 591
2 KIDNEY FUNCTION 76 23% 10% 297
3 DUAL BLOCKADE 55 56% 2% 68
4 TYPE 2 DIABETES 47 31% 4% 129
5 PROTEINURIA 47 11% 14% 407
6 BLOOD PRESSURE CONTROL 46 13% 11% 322
7 ACE INHIBITION 44 21% 6% 187
8 ANTIHYPERTENSIVE TREATMENT 37 16% 7% 215
9 NONDIABETIC NEPHROPATHIES 33 83% 1% 19
10 NONDIABETIC RENAL DISEASE 24 33% 2% 60

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Meta-analysis: Effect of monotherapy and combination therapy with inhibitors of the renin-angiotensin system on proteinuria in renal disease 2008 305 65 78%
Pathophysiology of progressive nephropathies 1998 784 72 42%
Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis 2012 29 40 65%
Mechanisms and Treatment of CKD 2012 36 100 50%
Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: A systematic review of the efficacy and safety data 2006 118 46 85%
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes 2006 284 95 33%
The RAAS in the pathogenesis and treatment of diabetic nephropathy 2010 70 97 44%
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials 2011 26 123 67%
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications 2005 173 105 45%
Understanding the nature of renal disease progression 1997 444 129 34%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MIDELFORT CLIN 7 53% 0.3% 9
2 NEGRI BERGAMO S 7 41% 0.4% 13
3 CLIN RARE DIS ALDO CELE DACCO 6 21% 0.8% 23
4 RUSH HYPERTENS 4 75% 0.1% 3
5 HEMODIALYSIS KIDNEY TRANSPLANTAT 4 56% 0.2% 5
6 WELLCOME TRUST CHILDRENS CLIN IL 2 67% 0.1% 2
7 MARIO NEGRI PHARMACOL 2 10% 0.6% 17
8 HYPERTENS DIS UNIT 1 14% 0.3% 10
9 BEREICH NEPHROL 1 50% 0.1% 2
10 CHIBRET 1 100% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000198540 DIABETIC GLOMERULOPATHY//NON DIABETIC RENAL DISEASE//STRUCTURAL FUNCTIONAL RELATIONSHIPS
2 0.0000180254 MICROALBUMINURIA//ALBUMINURIA//URINARY ALBUMIN EXCRETION
3 0.0000151884 RENAL FUNCTIONAL RESERVE//RENAL RESERVE//PROTEIN LOAD
4 0.0000102641 LATE REFERRAL//NEPHROLOGY REFERRAL//CHRONIC KIDNEY DISEASE CKD
5 0.0000091755 AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY
6 0.0000087588 HYPERTENS RENAL EXCELLENCE//URINARY ANGIOTENSINOGEN//RECEPTOR SIGNAL TRANSDUCT
7 0.0000081964 FDN CARDIOL//FISIOL TRANSLAC//TRANSLAT PHYSIOL
8 0.0000081402 POSTTRANSPLANTATION HYPERTENSION//POST TRANSPLANT NEPHROTIC SYNDROME//POST TRANSPLANT HYPERTENSION
9 0.0000078891 APOL1//APOLIPOPROTEIN L1//APOLIPOPROTEIN L
10 0.0000078426 TRANDOLAPRIL//MULTI PHOTON CONTAMINATION//VERAPAMIL SR TRANDOLAPRIL COMBINATION THERAPY